Intuitive Surgical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Intuitive Surgical (ISRG).

Price Target Range — 8 Quarters

Analyst Consensus — 25 Analysts

21Buy

3Hold

1Sell

Consensus RatingBuy# Analysts25Avg. Consensus PT$538Upside to Avg. PT+18.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 21, 2026	Leerink Partners	Mike Kratky	PT Raise	Outperform	$473→$503
Oct 21, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$450→$475
Oct 21, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	In-Line	$400→$385
Oct 21, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$487→$486
Oct 21, 2026	TD Cowen	Mathew Blackman	Maintained	Buy	$485
Oct 21, 2026	Barclays	Christopher Pasquale	PT Raise	Overweight	$485→$500
Oct 21, 2026	RBC Capital	Kendall Au	PT Cut	Outperform	$575→$550
Oct 21, 2026	Mizuho	Anthony Petrone	PT Cut	Neutral	$415→$400
Oct 21, 2026	Baird	David Rescott	PT Raise	Outperform	$513→$550
Oct 21, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$454
Oct 12, 2026	BTIG	Ryan Zimmerman	PT Cut	Buy	$469→$454
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$485
Sep 8, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$469
Aug 12, 2026	Oppenheimer	Suraj Kalia	Upgrade	Perform→Outperform	$500
Jul 30, 2026	HSBC	Helen Fang	Downgrade	Buy→Hold	$931
Jul 28, 2026	UBS	Patrick Wood	Assumes	Neutral→Buy	$550→$500
Jul 17, 2026	Raymond James	Jayson Bedford	PT Cut	Outperform	$577→$483
Jul 17, 2026	Piper Sandler	Adam Maeder	PT Cut	Overweight	$580→$470
Jul 17, 2026	JP Morgan	Robbie Marcus	PT Cut	Overweight	$550→$450
Jul 17, 2026	Mizuho	Anthony Petrone	PT Cut	Neutral	$500→$400

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on Intuitive Surgical, Raises Price Target to $503

Leerink Partners analyst Mike Kratky maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and raises the price target from $473 to $503.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Intuitive Surgical, Raises Price Target to $475

JP Morgan analyst Robbie Marcus maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and raises the price target from $450 to $475.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains In-Line on Intuitive Surgical, Lowers Price Target to $385

Evercore ISI Group analyst Vijay Kumar maintains Intuitive Surgical (NASDAQ:ISRG) with a In-Line and lowers the price target from $400 to $385.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Intuitive Surgical, Lowers Price Target to $486

Wells Fargo analyst Larry Biegelsen maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and lowers the price target from $487 to $486.

Benzinga Newsdesk

PRO
TD Cowen Reiterates Buy on Intuitive Surgical, Maintains $485 Price Target

TD Cowen analyst Mathew Blackman reiterates Intuitive Surgical (NASDAQ:ISRG) with a Buy and maintains $485 price target.

Benzinga Newsdesk

These Analysts Revise Their Forecasts On Intuitive Surgical After Q3 Results

Intuitive Surgical beat Q3 revenue and earnings estimates, raised procedure outlook, but shares fell 5.8% as analysts adjusted price targets.

Avi Kapoor

Intuitive Surgical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Intuitive Surgical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on Intuitive Surgical, Raises Price Target to $503

PRO
JP Morgan Maintains Overweight on Intuitive Surgical, Raises Price Target to $475

PRO
Evercore ISI Group Maintains In-Line on Intuitive Surgical, Lowers Price Target to $385

PRO
Wells Fargo Maintains Overweight on Intuitive Surgical, Lowers Price Target to $486

PRO
TD Cowen Reiterates Buy on Intuitive Surgical, Maintains $485 Price Target

These Analysts Revise Their Forecasts On Intuitive Surgical After Q3 Results

People Also Watch

People Also Watch

Intuitive Surgical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Intuitive Surgical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLeerink Partners Maintains Outperform on Intuitive Surgical, Raises Price Target to $503

PROJP Morgan Maintains Overweight on Intuitive Surgical, Raises Price Target to $475

PROEvercore ISI Group Maintains In-Line on Intuitive Surgical, Lowers Price Target to $385

PROWells Fargo Maintains Overweight on Intuitive Surgical, Lowers Price Target to $486

PROTD Cowen Reiterates Buy on Intuitive Surgical, Maintains $485 Price Target

These Analysts Revise Their Forecasts On Intuitive Surgical After Q3 Results

People Also Watch

People Also Watch

PRO
Leerink Partners Maintains Outperform on Intuitive Surgical, Raises Price Target to $503

PRO
JP Morgan Maintains Overweight on Intuitive Surgical, Raises Price Target to $475

PRO
Evercore ISI Group Maintains In-Line on Intuitive Surgical, Lowers Price Target to $385

PRO
Wells Fargo Maintains Overweight on Intuitive Surgical, Lowers Price Target to $486

PRO
TD Cowen Reiterates Buy on Intuitive Surgical, Maintains $485 Price Target